A discarded plastic tarp got tangled around a deer’s head. A passerby cut it free and rescued the animal.
People dumping plastic in the
forests need to be stopped.
— Куда мы катимся?
— Вот именно! С одной стороны — небывалый технический прогресс, с другой — небывалое духовное убожество.
Маргарет Брентон
"Жемчуг проклятых"
We are not separate from the Earth.
We ARE the Earth.
The rivers flow through us.
The trees breathe with us.
The wind carries our breath.
The fire reminds us of our spirit.
When we hurt the Earth, we hurt ourselves.
When we heal her, we heal ourselves.
It is time to listen again to the wisdom of the elders, to the forest, to the rivers, and to our hearts.
Not as a teacher, but as a bridge.
So that we may remember where we truly belong.
Scientists in Japan have developed a groundbreaking treatment that could double the average lifespan of cats, extending it from around 15 years to nearly 30 years.
The key lies in a protein called AIM (Apoptosis Inhibitor of Macrophage), discovered by Dr. Toru Miyazaki. While cats naturally produce AIM, they lack the ability to activate it effectively. This deficiency leads to the gradual buildup of waste in the kidneys, the leading cause of death in domestic cats.
Dr. Miyazaki’s team created an injectable form of activated AIM that directly restores the kidneys’ natural cleaning function. In clinical trials, cats with advanced kidney disease showed dramatic improvement after treatment. The therapy works both as a preventive measure for healthy cats and as a treatment for those already ill.
If approved, the treatment could revolutionize feline healthcare. Commercial rollout is expected to begin in Japan as early as 2025, with wider availability projected for 2027.
The research has also sparked interest for its potential applications in human medicine, as the AIM protein plays a similar waste-clearing role across species.